PRAC concludes there is no clear and consistent evidence of a difference in inhibitor development between classes of factor VIII medicines - Bulgarian Drug Agency

For citizens

For companies

For medical specialists

: Pharmacovigilance / «Medical specialists»; 19 May 2017

PRAC concludes there is no clear and consistent evidence of a difference in inhibitor development between classes of factor VIII medicines

PRAC concludes there is no clear and consistent evidence of a difference in inhibitor development between classes of factor VIII medicines.

More information is available below:

PRAC concludes there is no clear and consistent evidence of a difference in inhibitor development between classes of factor VIII medicines